| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |